Latest News and Press Releases
Want to stay updated on the latest news?
-
Stablecon, the conference for leaders at the intersection of stablecoins and financial services, announces fundraise and launch of new conference.
-
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
-
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
-
IGEL Now & Next 2025 unites IT leaders and partners in Frankfurt to drive secure, adaptive endpoint transformation, digital sovereignty, and resilience
-
EDMONTON, AB, Oct. 30, 2025 (GLOBE NEWSWIRE) -- With more than 55% of Alberta's construction injuries happening to workers in their first year at a company, the Alberta Construction Safety...
-
October 29, 2025 12:46 ET | Source: Organizing Committee of the 2025 Northeast Asia (Shenyang) Conference on Exchange of Professionals
SHENYANG, China, Oct. 29, 2025 (GLOBE NEWSWIRE) -- On October 26, the 2025 Northeast Asia (Shenyang) Conference on Exchange of Professionals and "Hundred Elites and Hundred Enterprises" Shenyang...
-
Second annual user conference unveils innovations and partnerships that advance the art of video storytelling Grammy Winner 2 Chainz and Emmy-Winning entrepreneur Tabitha Brown to headline sold-out...
-
TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing...
-
Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer,...
-
JENA, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...